
Welcome to the European Society for Micrograhic Surgery (ESMS)
The ESMS is a group of European-based dermatologists committed to maintaining high standards in micrographic surgery for skin cancer, especially using the Mohs technique.
There are several forms of micrographic surgery, but Mohs surgery has proven to be the most effective treatment for many types of skin cancer. It offers the highest potential for cure, even when other treatments have failed.
Mohs surgery is a highly specialised procedure. Therefore, it should be performed by board-certified dermatologists with specific training.
We are a sister society of the EADV (European Academy of Dermatology and Venereology), the main professional body or board certified dermatologists in Europe.
More about hte microgrphic surgery technique and its practioners.
Become a member and join the community
We welcome new members who are active in the field of micrographic surgery, or alternatively, have a professional interest in this area. As a member, you gain access to training opportunities, scientific exchange, and ongoing updates in the field.
In addition, ESMS also organises Mohs Surgery and Lab Technician Courses, supporting the next generation of surgeons and technicians in Europe.
Membership types
There are several kind of memberships, please see them all below.
Certified
-
50 Euro yearly
-
Specialists in Dermatology who actively perform micrographic surgery in accordance with ESMS standards are eligible to become certified members. This membership grants full rights within the association
-
Full access to ESMS meetings and activities
-
Voting rights at the general meeting, provided membership fees are paid
-
Possibility to be shown on the "Find a practioner" site
Associate
-
50 Euro yearly
-
Physicians with an interest in micrographic surgery are welcome to join the ESMS as associate members. This membership offers opportunities for learning and engagement within the society, with the following conditions:
-
Eligible to receive ESMS communications and participate in selected courses and activities.
-
Not permitted to vote at the general meeting or be elected to the board of directors.
-
May not use membership status in any form of publicity.
Resident
-
50 Euro 3 years
-
Residents or fellows in ESMS-recognized training centres may become associate members until they qualify for ordinary membership. (Their membership fee is waived for the first two years.)
-
Eligible to receive ESMS communications and participate in selected courses and activities.
-
Not permitted to vote at the general meeting or be elected to the board of directors (exempt LT board member role).
-
May not use membership status in any form of publicity.
Lab Technician
-
25 Euro yearly
-
Lab technicians currently performing or interested in performing frozen Mohs sections are encouraged to join ESMS as LT members. This category supports educational and networking opportunities, under the following terms:
-
Eligible to receive ESMS communications and participate in selected courses and activities.
-
Not permitted to vote at the general meeting or be elected to the board of directors (exempt LT board member role).
-
May not use membership status in any form of publicity.
Certified Lab Technician
-
25 Euro yearly
-
Specialist Lab technician who actively perform frozen johnsections during the Mohs surgery in accordance with ESMS standards are eligible to becoom ecertifies members.
-
Full access to ESMS LT meetings and ESMS meetings and actvities
-
Voting rights at the general meeting, provided membership fees are paid
-
Possibillity to be shown on the "Find a practioner"stie
Where to next? Learn more about the ESMS Society
The European Society of Micrographic Surgery (ESMS)
The ESMS is a group of European-based dermatologists committed to maintaining high standards in micrographic surgery for skin cancer, especially using the Mohs technique.
There are several forms of micrographic surgery, but Mohs surgery has proven to be the most effective treatment for many types of skin cancer. It offers the highest potential for cure, even when other treatments have failed.